期刊
MOLECULAR BIOLOGY OF THE CELL
卷 32, 期 19, 页码 1807-1817出版社
AMER SOC CELL BIOLOGY
DOI: 10.1091/mbc.E21-02-0064
关键词
-
类别
资金
- National Institutes of Health [R15 CA235749]
This study identified a new regulatory mechanism of the Hh pathway involving the interaction between PDE4D3 and Mmg, and how Mmg loss can suppress the growth of MB, providing a promising therapeutic avenue for Hh-related cancers with reduced side effects.
Mutations in the hedgehog (Hh) signaling are implicated in birth defects and cancers, including medulloblastoma (MB), one of the most malignant pediatric brain tumors. Current Hh inhibitors face the challenge of drug resistance and tumor relapse, urging new insights in the Hh pathway regulation. Our previous study revealed how PDE4D controls global levels of CAMP in the cytoplasm to positively regulate Hh signaling; in the present study, we found that a specific isoform PDE4D3 is tethered to the centrosome by Myomegalin (Mmg), a centrosome/Golgi-associated protein. Mmg loss dislocates PDE4D3 from the centrosome, leading to local PKA overactivation and inhibition of the Hh signaling, leaving other PKA-related pathways unaffected. Mmg loss suppresses the proliferation of granule neuron precursors and blocks the growth of MB in mouse model. Our findings specify a new regulatory mechanism of the Hh pathway and highlight an exciting therapeutic avenue for Hh-related cancers with reduced side effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据